Alzheimer's disease Clinical Trials
Recruiting alzheimer's disease studies with sites across the US, sourced from ClinicalTrials.gov and refreshed daily. Free to join — find one near you below.
Clinical trials study new ways to prevent, detect, or treat alzheimer's disease. Joining one can give you access to investigational treatments and close monitoring by a specialist research team — at no cost — while helping advance care for others. Below are recruiting alzheimer's disease studies with sites across the US; use the location tools to find ones near you.
What to expect
- Screening first. The study team reviews your eligibility before anything else — there's no obligation to continue.
- Informed consent. You'll get a full explanation of the study, its potential risks and benefits, and can withdraw at any time.
- No cost to you. Study visits, tests, and the investigational treatment are covered; many studies reimburse travel.
Recruiting alzheimer's disease trials
Vagus Nerve Stimulation to Enhance Memory in Aging
Electroconvulsive Therapy for Treatment of Alzheimer´s Disease
Tricaprilin Phase 3 ALTER-AD (Alternative-Alzheimer Disease) Study
A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease
Alzheimer's Tau Platform: Regimen A - AADvac1
A Phase 2b/3 Clinical Study Evaluating T3D-959 in Mild-to-Moderate Alzheimer's Disease Subjects
The Care for America's Aging Study
Validation Study of the ExéSem Battery Designed to Differentiate the Contribution of Executive Functions in Semantic Disorders
The Gut - PRO Study
A Study of GSM-779690T in Healthy Adult Participants
Novel Brain Stimulation Treatment for Neuropsychiatric Symptoms in Alzheimer's Disease
Amyloid Lowering for Alzheimer's in Down's With Donanemab Investigation
A Study to Evaluate the Safety, Tolerability, and Efficacy of TML-6 in Participants With Early Alzheimer's Disease
Using Artificial Intelligence to Detect Early Signs of Alzheimer's Disease in People With Memory Concerns
Cholinergic Deep Brain Stimulation for Alzheimer's Disease
Automated, Assistive, Non-Contact Sleep Quality Monitor for Individuals With Alzheimer's Disease
Evaluation System for Lecanemab Efficacy Using Gold Electrode ECL to Monitor Alzheimer's Biomarkers
Alzheimer's Tau Platform: Master Protocol
Implementation of AIP Services for Older Adults With AD
Deep Cervical Lymphovenous Anastomosis for Moderate Alzheimer's Disease
A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease
Masitinib in Patients With Mild Alzheimer's Disease
Effects of Ginkgo Biloba on Blood Biomarkers in Mild Cognitive Impairment
AV-1980R (Tau Vaccine) in Preclinical Alzheimer's Disease (TAURUS-1980)
Music for Pain and Dementia
Silkworm Pupa Powder Improves Alzheimer's Disease
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
A Study of LY3439539 in Participants With Alzheimer's Disease
A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease
Wearables-and Blood-based Biomarkers-incorporated Modernisation of Circadian Rhythm Disruption Management in People Living With Alzheimer's Dementia: A Stepwise Study From Digital Inclusivity, Digital Therapy, to Digital Phenotyping and Biomarker Exploration
Allogeneic Adipose Tissue Derived-stem Cells in Alzheimer Disease
Deep Learning on Amyloid Positons Emission Tomography
Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease
Links Between Self-awareness and Sociocognitive Processes in Neurodegenerative Diseases
Safety Assessment of Leronlimab and Its Effect on Brain Inflammation in Alzheimer's Disease
Donanemab (LY3002813) Trial in Chinese Participants With Cognitively Unimpaired (Preclinical) Alzheimer's Disease
DIV-AD BARCELONA: Alzheimer's Blood-Based Biomakers for a Diverse Community
The Underlying Neural Mechanism of TMS in Improving the Imbalance of "Microbiota-brain-gut Axis" in Alzheimer 's Disease Population
Tele-Savvy for Latino Caregivers
Biomarker-based Trial of NPC-1 for Alzheimer's Pathology
An Investigation Into the Feasibility of Beetroot Juice Supplementation in People Living With Alzheimer's Disease.
Use of Wearables for Identifying Factors Associated With Mild Cognitive Impairment and Early-Stage Alzheimer's Disease
A Study to Compare Two Different Sleep Tests in Participants With No Symptoms or Early Symptoms of Alzheimer's Disease
A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)
Deep Cervical LymphatIc-Venous Anastomosis for Alzheimer's Disease
Blood Biomarkers for Early and Accurate Diagnosis of Alzheimer's Disease in Primary Care
Retrospective Observational Study of Blood-based Biomarkers in the Diagnosis and Monitoring of Patients With a Neurodegenerative Disease or Mental Disorder
Learning Amyloid and Tau Results
WeCareToFeedDysphagia to Reduce Care-partner Burden Full-scale RCT
Comparative Study of High Performance Low-Cost Optical Coherence Tomography (Stage 1B, 2 and 3)
Biomarkers of the Locus Coeruleus Nucleus: Links With Early Tau Pathology, Cognition and Alzheimer's Disease Risk
Prospective Observational Study of the Relationship Between Sociodemographic Factors, Blood-based Biomarkers and Psychiatric Symptoms in Neurodegenerative Diseases and Mental Disorders
Lombard Cohort of Brain Health Services
Combined Brain Stimulation and Methylphenidate Treatment for Apathy in Dementia
Repeat Intracerebroventricular Injections of RB-ADSC in Subjects Previously Treated in RBI Protocol RB-ADSC-02
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7812653 in Participants With Early Symptomatic Alzheimer's Disease (eAD)
Fisetin in Mild Alzheimer's Disease
Alzheimer's disease clinical trials — common questions
Are alzheimer's disease clinical trials free to join?
Yes. Participating in a alzheimer's disease clinical trial is free — study-related visits, tests, and the investigational treatment are provided at no cost to you. Many studies also reimburse travel and time. You never pay to take part.
Who can join a alzheimer's disease clinical trial?
Each alzheimer's disease study sets its own eligibility criteria — typically based on age, medical history, current treatments, and overall health. Every trial listed here shows its criteria, and the study team confirms your eligibility before enrollment. You can review and apply to any that look like a fit.
How do I find a alzheimer's disease trial near me?
Use the location controls above. We'll show recruiting alzheimer's disease trials with sites near you, sorted by distance. You can widen the radius or share your exact location for the closest matches.
How many alzheimer's disease trials are recruiting right now?
We're currently tracking roughly 222 recruiting alzheimer's disease trials with US sites, sourced from ClinicalTrials.gov and refreshed daily.
Looking for a specific location? Browse trials by city and state.